Quality indicators for the care and outcomes of adults with atrial fibrillation: Task Force for the development of quality indicators in atrial fibrillation of the European …

E Arbelo, (Chair), S Aktaa, A Bollmann, A D'Avila… - Ep …, 2021 - academic.oup.com
Aims To develop quality indicators (QIs) that may be used to evaluate the quality of care and
outcomes for adults with atrial fibrillation (AF). Methods and results We followed the ESC …

Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology

G Boriani, M Vitolo, DA Lane, TS Potpara… - European Journal of …, 2021 - Elsevier
The most recent atrial fibrillation (AF) guidelines delivered by European Society of
Cardiology (ESC) offer an updated approach to AF management, with the perspective of …

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial

A Metzner, A Suling, A Brandes, G Breithardt… - EP …, 2022 - academic.oup.com
Aims Treatment patterns were compared between randomized groups in EAST-AFNET 4 to
assess whether differences in anticoagulation, therapy of concomitant diseases, or intensity …

Association between metabolically healthy obesity and risk of atrial fibrillation: taking physical activity into consideration

R Wang, I Olier, S Ortega-Martorell, Y Liu, Z Ye… - Cardiovascular …, 2022 - Springer
The modification of physical activity (PA) on the metabolic status in relation to atrial
fibrillation (AF) in obesity remains unknown. We aimed to investigate the independent and …

The 2020 ESC atrial fibrillation guidelines for atrial fibrillation catheter ablation, CABANA, and EAST

E Arbelo, N Dagres - Ep Europace, 2022 - academic.oup.com
Prior randomised clinical trials (RCTs) have suggested that rhythm control offers no benefit
compared to accepting AF and instituting rate control in terms of all-cause mortality, CV …

ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project

H Heidbuchel, IC Van Gelder, L Desteghe… - 2022 - academic.oup.com
Transforming health care is a difficult task: although physicians know which evidence-based
treatments work, delivering those in a unified fashion as integrated management often lacks …

[HTML][HTML] Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation

P Mołek, J Chmiel, M Ząbczyk, KP Malinowski… - International Journal of …, 2022 - Elsevier
Background Enhanced oxidative stress occurs in atrial fibrillation (AF), however its impact on
the efficacy and safety of anticoagulation is unknown. We sought to evaluate whether 8 …

The gray areas of oral anticoagulation for prevention of thromboembolic events in atrial fibrillation patients

A Curcio, M Anselmino, L Di Biase… - Journal of …, 2023 - journals.lww.com
Thromboembolic events (TEE) associated with atrial fibrillation (AF) are highly recurrent and
usually severe, causing permanent disability or, even, death. Previous data consistently …

Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and …

M Sterliński, KV Bunting, G Boriani, S Boveda… - Europace, 2024 - academic.oup.com
Aims The aim is to describe the rationale, design, delivery, and baseline characteristics of
the Stroke prevention and rhythm control Treatment: Evaluation of an Educational …

Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry.

M Proietti, G Romiti, M Vitolo… - … journal. Quality of …, 2022 - avesis.hacettepe.edu.tr
Aims Bleeding risk assessment is recommended in guidelines for the management of atrial
fibrillation (AF). The HAS-BLED score was proposed prior to non-vitamin K antagonist oral …